Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Imfinzi (durvalumab)
August 18, 2024
ASCO 2024 – Major Advances in the Treatment of Lung Cancer
Dr. C H Weaver MD
April 11, 2024
Checkpoint Inhibitor – Chemotherapy for Treatment of Small Cell Lung Cancer
Dr. C H Weaver MD
November 11, 2023
Immunotherapy Plus TACE A New Standard for Unresectable Liver Cancer?
Dr. C H Weaver MD
October 27, 2023
Perioperative and Neoadjuvant Immunotherapy in Early Stage Lung Cancer
Dr. C H Weaver MD
October 24, 2023
Keytruda & Other Checkpoint Inhibitors for Triple Negative Breast Cancer
Dr. C H Weaver MD
October 17, 2023
Imfinzi in Non-Small Cell Lung Cancer
Dr. C H Weaver MD
January 25, 2023
Tecentriq-Avastin for Early Stage Liver Cancer
Dr. C H Weaver MD
October 26, 2021
Imfinzi Plus Chemotherapy Improves Survival in Advanced Biliary Tract Cancers
Dr. C H Weaver MD
April 13, 2021
Treatment of Stage I – III Non-Small Cell Lung Cancer
Dr. C H Weaver MD
February 6, 2021
Treatment of Stage III B – IV Non-Small Cell Lung Cancer
Dr. C H Weaver MD
August 7, 2020
Treatment & Management of Liver Cancer
Dr. C H Weaver MD
March 8, 2020
Imfinzi for Treatment of Urothelial Cancer
Dr. C H Weaver MD
1
2
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
